Public disclosures

Shah Gaurav

Company insiders · CEO · ROCKET PHARMACEUTICALS, INC.

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-20.Following & alerts
Reported transaction lines
2
Buy lines
0
Sell lines
2

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-112

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
Shah Gaurav

CEO · ROCKET PHARMACEUTICALS, INC.

RCKT

ROCKET PHARMACEUTICALS, INC.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 1051358 · SEC code covers open-market or private transactions · Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. · The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.

2026-11-182026-11-20

≈ $4,826.45

2,216 shares/units

SEC 4
Shah Gaurav

CEO · ROCKET PHARMACEUTICALS, INC.

RCKT

ROCKET PHARMACEUTICALS, INC.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 1053574 · SEC code covers open-market or private transactions · Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. · The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.

2026-11-132026-11-17

≈ $6,795.00

3,020 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement